President Biden last Friday nominated career civil servant Christi Grimm to serve as Inspector General of the U.S. Health and Human Services Department (HHS).
The HHS Office of Inspector General (OIG) has issued numerous reports on the 340B program on topics including contract pharmacy arrangements, state efforts to prevent duplicate 340B discounts and Medicaid rebates, Medicare Part B payments for 340B-purchased drugs, and drug manufacturer overcharges for covered outpatient drugs.
President Biden last Friday nominated career civil servant Christi Grimm to serve as Inspector General of the U.S. Health and Human Services Department (HHS).
The HHS Office of Inspector General (OIG) has issued numerous reports on the 340B program on topics including contract pharmacy arrangements, state efforts to prevent duplicate 340B discounts and Medicaid rebates, Medicare Part B payments for 340B-purchased drugs, and drug manufacturer overcharges for covered outpatient drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
